Wall Street brokerages expect Omega Healthcare Investors Inc (NYSE:OHI) to post sales of $219.07 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Omega Healthcare Investors’ earnings, with the lowest sales estimate coming in at $217.60 million and the highest estimate coming in at $220.99 million. Omega Healthcare Investors reported sales of $234.49 million during the same quarter last year, which indicates a negative year-over-year growth rate of 6.6%. The company is scheduled to report its next quarterly earnings report on Wednesday, February 14th.

On average, analysts expect that Omega Healthcare Investors will report full-year sales of $219.07 million for the current financial year, with estimates ranging from $905.04 million to $936.00 million. For the next fiscal year, analysts forecast that the company will post sales of $933.07 million per share, with estimates ranging from $898.76 million to $958.00 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that cover Omega Healthcare Investors.

OHI has been the topic of several research analyst reports. Zacks Investment Research lowered Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. SunTrust Banks reissued a “hold” rating and set a $30.00 price target on shares of Omega Healthcare Investors in a research report on Wednesday, November 1st. Cantor Fitzgerald initiated coverage on Omega Healthcare Investors in a research report on Wednesday, December 20th. They set an “overweight” rating and a $34.00 price target on the stock. Vetr lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $33.33 price target on the stock. in a research report on Thursday, October 19th. Finally, Jefferies Group reissued an “underperform” rating on shares of Omega Healthcare Investors in a research report on Thursday, December 21st. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $32.14.

In related news, Director Bernard J. Korman purchased 100,000 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, December 22nd. The shares were purchased at an average cost of $26.89 per share, with a total value of $2,689,000.00. Following the transaction, the director now owns 896,895 shares of the company’s stock, valued at approximately $24,117,506.55. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Craig R. Callen acquired 10,000 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were acquired at an average price of $27.38 per share, for a total transaction of $273,800.00. The disclosure for this purchase can be found here. Insiders have purchased a total of 210,000 shares of company stock worth $5,786,800 over the last three months. 1.54% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. Meridian Investment Counsel Inc. increased its holdings in Omega Healthcare Investors by 0.7% during the 2nd quarter. Meridian Investment Counsel Inc. now owns 35,164 shares of the real estate investment trust’s stock worth $1,161,000 after purchasing an additional 250 shares during the last quarter. M&R Capital Management Inc. increased its holdings in Omega Healthcare Investors by 1.3% during the 2nd quarter. M&R Capital Management Inc. now owns 30,940 shares of the real estate investment trust’s stock worth $937,000 after purchasing an additional 385 shares during the last quarter. Atlantic Trust Group LLC increased its holdings in Omega Healthcare Investors by 2.4% during the 2nd quarter. Atlantic Trust Group LLC now owns 22,376 shares of the real estate investment trust’s stock worth $739,000 after purchasing an additional 529 shares during the last quarter. First City Capital Management Inc. increased its holdings in Omega Healthcare Investors by 3.0% during the 2nd quarter. First City Capital Management Inc. now owns 25,976 shares of the real estate investment trust’s stock worth $858,000 after purchasing an additional 765 shares during the last quarter. Finally, Moors & Cabot Inc. increased its holdings in Omega Healthcare Investors by 10.8% during the 2nd quarter. Moors & Cabot Inc. now owns 8,829 shares of the real estate investment trust’s stock worth $295,000 after purchasing an additional 859 shares during the last quarter. Institutional investors own 67.95% of the company’s stock.

Omega Healthcare Investors (NYSE OHI) traded down $0.19 during midday trading on Friday, hitting $26.96. The stock had a trading volume of 3,200,000 shares, compared to its average volume of 2,380,000. The firm has a market cap of $5,320.00, a price-to-earnings ratio of 35.47, a P/E/G ratio of 2.78 and a beta of 0.49. Omega Healthcare Investors has a fifty-two week low of $26.43 and a fifty-two week high of $35.14. The company has a quick ratio of 3.40, a current ratio of 3.40 and a debt-to-equity ratio of 1.18.

COPYRIGHT VIOLATION WARNING: This article was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2018/01/07/omega-healthcare-investors-inc-ohi-expected-to-announce-quarterly-sales-of-219-07-million.html.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Get a free copy of the Zacks research report on Omega Healthcare Investors (OHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.